<VariationArchive RecordType="classified" VariationID="18295" VariationName="NM_000485.3(APRT):c.321+2dup" VariationType="Duplication" Accession="VCV000018295" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-10-30" DateCreated="2015-08-05" MostRecentSubmission="2020-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="33334" VariationID="18295">
      <GeneList>
        <Gene Symbol="APRT" FullName="adenine phosphoribosyltransferase" GeneID="353" HGNC_ID="HGNC:626" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88809339" stop="88811928" display_start="88809339" display_stop="88811928" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88875876" stop="88878341" display_start="88875876" display_stop="88878341" Strand="-" />
          </Location>
          <OMIM>102600</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000485.3(APRT):c.321+2dup</Name>
      <CanonicalSPDI>NC_000016.10:88810420:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88810420" stop="88810421" display_start="88810420" display_stop="88810421" variantLength="1" positionVCF="88810420" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88876828" stop="88876829" display_start="88876828" display_stop="88876829" variantLength="1" positionVCF="88876828" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88810421dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88810421dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88876829dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88876829dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008013.1" sequenceAccession="NG_008013" sequenceVersion="1" change="g.6514dup">
            <Expression>NG_008013.1:g.6514dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028266.1" sequenceAccession="NG_028266" sequenceVersion="1" change="g.11644dup">
            <Expression>NG_028266.1:g.11644dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000485.3" sequenceAccession="NM_000485" sequenceVersion="3" change="c.321+2dup" MANESelect="true">
            <Expression>NM_000485.3:c.321+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001030018.2" sequenceAccession="NM_001030018" sequenceVersion="2" change="c.321+2dup">
            <Expression>NM_001030018.2:c.321+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000485.2" sequenceAccession="NM_000485" sequenceVersion="2" change="c.321+2dup">
            <Expression>NM_000485.2:c.321+2dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA343886" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="102600.0002" DB="OMIM" />
        <XRef Type="rs" ID="281860263" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000485.3(APRT):c.321+2dup AND Adenine phosphoribosyltransferase deficiency" Accession="RCV000033907" Version="7">
        <ClassifiedConditionList TraitSetID="8113">
          <ClassifiedCondition DB="MedGen" ID="C0268120">Adenine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-08-05" MostRecentSubmission="2020-12-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">3680503</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2135300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7685481</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9298830</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8113" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6494" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adenine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="MONDO:0013869" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydroxyadeninuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">UROLITHIASIS, 2,8-DIHYDROXYADENINE</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROLITHIASIS, DHA</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">APRTD</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adenine phosphoribosyltransferase (APRT) deficiency is characterized by excessive production and renal excretion of 2,8-dihydroxyadenine (DHA), which leads to kidney stone formation and crystal-induced kidney damage (i.e., DHA crystal nephropathy) causing acute kidney injury episodes and progressive chronic kidney disease (CKD). Kidney stones, the most common clinical manifestation of APRT deficiency, can occur at any age; in at least 50% of affected persons symptoms do not occur until adulthood. If adequate treatment is not provided, approximately 20%-25% of affected individuals develop end-stage renal disease (ESRD), usually in adult life.</Attribute>
                <XRef ID="NBK100238" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22934314</ID>
                <ID Source="BookShelf">NBK100238</ID>
              </Citation>
              <XRef ID="976" DB="Orphanet" />
              <XRef ID="C0268120" DB="MedGen" />
              <XRef ID="MONDO:0013869" DB="MONDO" />
              <XRef Type="MIM" ID="614723" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="40255" SubmissionDate="2015-08-03" DateLastUpdated="2015-08-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="102600.0002_APRT DEFICIENCY" title="APRT, 1-BP INS, 1834T_APRT DEFICIENCY" />
        <ClinVarAccession Accession="SCV000040255" DateUpdated="2015-08-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp insertion in the APRT gene (1834insT) that was found in compound heterozygous state in a lymphoblastoid cell line from a patient with complete APRT deficiency (614723) by Hidaka et al. (1987), see 102600.0001.</Attribute>
              <Citation>
                <ID Source="PubMed">3680503</ID>
              </Citation>
              <XRef DB="OMIM" ID="614723" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In identical twin brothers born to nonconsanguineous German parents with APRT deficiency, Gathof et al. (1991) identified a homozygous 1-bp insertion in the splice donor site of intron 4 of the APRT gene (the numbering system used by Gathof et al. (1991) indicated that the insertion was between bases 1831 and 1832 or 1832 and 1833). The insertion resulted in aberrant splicing. They quoted finding of the same mutation in 2 other Caucasian patients living in the U.S., and as 1 of 2 alleles in a Belgian patient with compound heterozygous APRT mutations (Hidaka et al., 1987).</Attribute>
              <Citation>
                <ID Source="PubMed">2135300</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3680503</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Menardi et al. (1997) demonstrated homozygosity for this common T insertion at the exon 4/intron 4 junction, resulting in the lack of exon 4 in the APRT mRNA. This common splice site mutation had always been found in association with a TaqI RFLP, leading to the proposal that this splice site mutation originated from a single event (Chen et al., 1993). However, Menardi et al. (1997) found a patient with this mutation who was negative for the TaqI RFLP. The position of this T insertion suggested it was a hotspot for mutational events (Chen et al., 1993).</Attribute>
              <Citation>
                <ID Source="PubMed">9298830</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7685481</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APRT" />
          </GeneList>
          <Name>APRT, 1-BP INS, 1834T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1834T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="102600.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">APRT DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2862010" SubmissionDate="2020-11-13" DateLastUpdated="2020-12-11" DateCreated="2020-12-11">
        <ClinVarSubmissionID localKey="NM_000485.2:c.321+2dup|OMIM:614723" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001449087" DateUpdated="2020-12-11" DateCreated="2020-12-11" Type="SCV" Version="1" SubmitterName="APRT Deficiency Research Program of the Rare Kidney Stone Consortium, Landspitali, National University Hospital of Iceland" OrgID="507801" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2135300</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APRT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000485.2:exon 3</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000485.2:c.321+2dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614723" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8542258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2862010" TraitType="Disease" MappingType="XRef" MappingValue="614723" MappingRef="OMIM">
        <MedGen CUI="C0268120" Name="Adenine phosphoribosyltransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="40255" TraitType="Disease" MappingType="Name" MappingValue="APRT DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C0268120" Name="Adenine phosphoribosyltransferase deficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2019-10-24">SCV000057821</Accession>
        <Description>This variant is no longer cited in the GeneReview and has been deleted.</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

